The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The challenges of repeat biopsies at acquired resistance to EGFR TKIs.
 
Meghan Campo
No Relationships to Disclose
 
Zofia Piotrowska
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology
 
Alona Muzikansky
No Relationships to Disclose
 
Coleen Rizzo
No Relationships to Disclose
 
Justin F. Gainor
Consulting or Advisory Role - Boehringer Ingelheim; Jounce Therapeutics; Kyowa Hakko Kirin; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech
 
Jeffrey A. Engelman
Consulting or Advisory Role - Agios; Allosterix; Amgen; Asana Biosciences; AstraZeneca; Aveo/Biodesix; Cell Signaling Technology; Chugai Pharma; Clovis Oncology; EMD Serono; Endo Pharmaceuticals; G1 Therapeutics; GATEKEEPER Pharmaceuticals; Genentech; GlaxoSmithKline; Jounce Therapeutics; Kura Oncology; Loxo; Merck; Novartis; Sanofi; Synta; Ventana Medical Systems; Warp Drive Bio; Wellspring/Araxes
 
Lecia V. Sequist
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)